Upadacitinib improves symptoms of concomitant allergic rhinitis
or allergic asthma in patients with severe atopic dermatitis: A
16-week
multicentre retrospective study
Upadacitinib improves symptoms of concomitant allergic rhinitis
or allergic asthma in patients with severe atopic dermatitis: A
16-week
multicentre retrospective study
(2024)
Autori:
Gargiulo, L.; Ibba, L.; Piscazzi, F.; Balato, F. Amoruso. A.; Barei, F.; Bertello, M.; Burroni, A. G.; Caccavale, S.; Ferrucci, S. M.; Foti, C.; Gaiani, F. M.; Girolomoni, G.; Malagoli, P.; Marzano, A. V.; Maurelli, M.; Napolitano, M.; Nettis, E.; Ortoncelli, M.; Patruno, C.; Pezzolo, E.; Ribero, S.; Romita, P.; Rossi, M. T.; Zaza, I.; Guanti, M. B.; Costanzo, A.; Narcisi, A.
Titolo:
Upadacitinib improves symptoms of concomitant allergic rhinitis
or allergic asthma in patients with severe atopic dermatitis: A
16-week
multicentre retrospective study
Anno:
2024
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Referee:
No
Nome rivista:
Journal of the European Academy of Dermatology and Venereology
Atopic dermatitis (AD) is the most common inflammatory
skin disease often associated with comorbidities, including
allergic rhinitis (AR; 40.3% of patients) and allergic asthma
(AA; 51.3%).1 Among systemic treatments approved for severe
AD, dupilumab is also indicated for the treatment of
chronic rhinosinusitis with nasal polyps, AA and eosinophilic
esophagitis.2,3 Upadacitinib, a selective JAK1-inhibitor
approved for severe AD, lacks approval for AA and AR.4–6
We retrospectively analysed data from 11 Italian dermatology
units to determine whether upadacitinib could improve
symptoms related to AA or AR in patients with severe
AD.
Id prodotto:
140917
Handle IRIS:
11562/1134786
ultima modifica:
30 ottobre 2024
Citazione bibliografica:
Gargiulo, L.; Ibba, L.; Piscazzi, F.; Balato, F. Amoruso. A.; Barei, F.; Bertello, M.; Burroni, A. G.; Caccavale, S.; Ferrucci, S. M.; Foti, C.; Gaiani, F. M.; Girolomoni, G.; Malagoli, P.; Marzano, A. V.; Maurelli, M.; Napolitano, M.; Nettis, E.; Ortoncelli, M.; Patruno, C.; Pezzolo, E.; Ribero, S.; Romita, P.; Rossi, M. T.; Zaza, I.; Guanti, M. B.; Costanzo, A.; Narcisi, A.,
Upadacitinib improves symptoms of concomitant allergic rhinitis
or allergic asthma in patients with severe atopic dermatitis: A
16-week
multicentre retrospective study«Journal of the European Academy of Dermatology and Venereology»
, 2024
, pp. 743-746